Welcome to BioMarket Group!

Diabetes Market in UAE

Additional Information

Published Date Feb 15, 2011
Special Offer No
Pages 35
PDF Fact Sheet View Fact Sheet for the report Diabetes Market in UAE in PDF format.
Published on Date No
Format PDF
Publisher RNCOS
Product Line No
Full Title No

Availability: In stock

$800.00

Quick Overview

Diabetes is one of the fastest growing lifestyle and debilitating diseases in the Middle East region. At present, one out of every five person in the UAE is suffering from diabetes..
Request free sample pages from Diabetes Market in UAE

Diabetes is the world’s most costly epidemic. It is anticipated that, over 10% of the population in countries such as, the US, Malaysia, and Indonesia will be diabetic by 2020 and there will be over 300 Million diabetics worldwide. Similarly, the prevalence of diabetes has been increasing in the UAE as well. Diabetes in the UAE is becoming a major health issue with 19-25% of the UAE nationals or one in four people being diabetic. Viewing this, spending of the government as well as consumers has been continuously increasing in the country for the past few years. According to our new research report "Diabetes Market in UAE", amid increasing spending and prevalence of diabetes, the diabetes market in the country is anticipated to grow at a CAGR of 10% during 2011 - 2013.

We have studied the UAE diabetes market by segmenting it into - oral diabetic drug market, insulin market, and diabetes medical devices market. Medical devices market is further segmented into glucose monitoring market, insulin pump market, insulin pen market, and insulin syringes market. Each of these two segments have been thoroughly studied and analyzed in the report. Moreover, the report provides an overview of patient profile in the country, which will help clients to identify the future demand scenario.

Our report has also found that among the medical devices, insulin pump acquires a major share of the total diabetes market. The main factor responsible for such a sizeable share is the unique capability of the pump of delivering insulin automatically into the body directly. A number of other factors such as, epidemic proportion of diabetes, growing need for efficient control over blood sugar levels, and various insurance plans that include the expenditure of pump and supplies also support the growth of the market.

The report studies the current development process and its effects on various segments of the industry. The research provides detail statistical and analytical review of the macroeconomic indicators, key drivers, and restraints. It contains exhaustive information about the market players, government initiatives, and patients’ profile that will help clients to plan market strategies and assess opportunity areas in the UAE diabetes market.

The report also includes a section of future projection and demand analysis that provides a rough idea about the prospective market trends to facilitate clients’ understanding regarding the future growth of the market.

1. Analyst View
2. Research Methodology
3. Market Overview
4. Diabetes Market Analysis
4.1 Diabetes Care Market
4.2 Insulin Market
5. Patient Profile Analysis
6. Future Projection and Demand Analysis
7. Government Initiatives
8. Strategic Analysis of Key Players
8.1 Novo Nordisk
8.2 Bayer HealthCare
8.3 Sanofi Aventis
8.4 Medysinal Fze

List of Figures:

Figure 4-1: Diabetes Care Market (Million US$), 2007-2009
Figure 4-2: Insulin Market (Million US$), 2007-2009
Figure 5-1: Forecast for Prevalence of Diabetes (%), 2010 & 2030
Figure 5-2: Forecast for Prevalence of Impaired Glucose Tolerance (%), 2010 & 2030
Figure 5-3: Forecast for Number of Diabetic Population (’000), 2010-2012
Figure 6-1: Forecast for Diabetes Care Market (Million US$), 2010-2012
Figure 6-2: Forecast for Insulin Market (Million US$), 2010-2012

List of Table:

Table 5-1: Prevalence of Obesity by BMI (%), 2005

Request free sample pages from Diabetes Market in UAE

Other selected research from the 'United Arab Emirates' category:


Major Pharmaceutical Markets of the Middle East (2nd Ed)
A comprehensive report providing extensive coverage of one of the strongest emerging markets. An overview of Egypt, Israel, Jordan, Lebanon, Saudi Arabia & UAE Learn More


UAE Healthcare Sector Forecast to 2012
The UAE healthcare industry has shown an unprecedented growth over the past few years and is expected to continue growing in the future as well on the back of increasing... Learn More

Other selected research from the 'Metabolic disorders' category:


Diabetes and Pregnancy - Delivering Improved Outcomes
About one in 100 women of childbearing age have diabetes before pregnancy (pre-existing diabetes). Another 3-5% develop diabetes during pregnancy (gestational diabetes). While diabetes poses some risks in pregnancy, advances in healthcare have greatly improved the outlook for these pregnancies. However, untreated or poorly controlled gestational diabetes can seriously harm the fetus. Learn More


The Future of Metabolomics: Building competitive advantage in drug discovery, clinical development and diagnostics
The report also highlights the use of metabolomics in maximizing and sustaining revenues post-marketing and in the development of clinical diagnostics. Learn More